A 35-year-old woman comes to the clinic to discuss recent laboratory results. A basic metabolic panel obtained during a pre-employment physical examination showed an elevated serum calcium level. The patient feels completely well and has no fatigue, abdominal pain, bone pain, or changes in bowel habits. She has no significant past medical history and takes no medications or over-the-counter supplements. She exercises vigorously four times a week. Vital signs are within normal limits. Physical examination is unremarkable.
Laboratory studies reveal the following:
| Test | Result | Reference Range |
|---|---|---|
| Serum calcium | ||
| Serum phosphorus | ||
| Serum albumin | ||
| Serum creatinine | ||
| Intact parathyroid hormone | ||
| 25-hydroxyvitamin D | ||
| 24-hour urine calcium | ||
| 24-hour urine creatinine |
Which of the following is the most likely underlying mechanism for this patient's laboratory findings?
- Reduced sensitivity of transmembrane receptors in the parathyroid glands and kidneysAnswer
- BAutonomous overproduction of a peptide hormone by a monoclonal glandular proliferation
- CEnhanced extrarenal 1-alpha-hydroxylase activity by activated macrophages
- DEctopic secretion of a protein structurally homologous to a physiologic hormone
- EIncreased calcium reabsorption in the distal convoluted tubule due to pharmacologic blockade of sodium-chloride cotransporters
Answer
Reduced sensitivity of transmembrane receptors in the parathyroid glands and kidneys
The patient has asymptomatic hypercalcemia with an inappropriately normal intact parathyroid hormone (PTH) level. In a healthy individual, a serum calcium of would suppress PTH to near zero. A normal or elevated PTH in this setting indicates a PTH-dependent hypercalcemia, which is primarily caused by either primary hyperparathyroidism or familial hypocalciuric hypercalcemia (FHH). The key differentiating laboratory test is the 24-hour urine calcium or the urine calcium-to-creatinine clearance ratio (UCCR). This patient's 24-hour urine calcium is remarkably low (), and her UCCR is . This profile is classic for FHH. FHH is an autosomal dominant disorder caused by an inactivating mutation in the calcium-sensing receptor (CaSR), a G-protein-coupled receptor found primarily in the parathyroid glands and renal tubules. The mutation causes a decreased sensitivity to serum calcium, requiring a higher-than-normal calcium level to suppress PTH secretion, while also maximizing renal calcium reabsorption.
Step-by-Step Solution
Key Concept
Familial hypocalciuric hypercalcemia (FHH) presents with mild hypercalcemia, inappropriately normal-to-elevated parathyroid hormone, and marked hypocalciuria (UCCR < 0.01) due to a defective calcium-sensing receptor.
Estimated Time:2m 30s